Connect Biopharma Holdings Limited announced that it has completed full enrollment of the phase II clinical trial evaluating CBP-307 in adult patients with moderate-to-severe ulcerative colitis.
[Connect Biopharma Holdings Ltd.]
Sorry, but the selected Zotpress account can't be found.